Filed by the Registrant
|
☐
|
|
Filed by a Party other than the Registrant
|
☑
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☐
|
Definitive Proxy Statement
|
|
☑
|
Definitive Additional Materials
|
|
☐
|
Soliciting Material Pursuant to Rule 14a-12
|
☑
|
No fee required.
|
||
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||
(1)
|
Title of each class of securities to which transaction applies:
|
||
(2)
|
Aggregate number of securities to which transaction applies:
|
||
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
||
(4)
|
Proposed maximum aggregate value of transaction:
|
||
(5)
|
Total fee paid:
|
||
☐
|
Fee paid previously with preliminary materials.
|
||
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
(1)
|
Amount Previously Paid:
|
||
(2)
|
Form, Schedule or Registration Statement No.:
|
||
(3)
|
Filing Party:
|
||
(4)
|
Date Filed:
|
·
|
HEWA reveals its plans to spend $180,000 to oppose stockholder efforts to transform our company, more than the available cash HEWA reported on June 30, 2016. It has already spent $140,000 to-date. This decision to spend and defend coincides with an equivalent increase in the credit line controlled by the company's senior lender and Series B holder. Spending our stockholder money to defend their poor performance and preserve their jobs, all while increasing our company's already crushing debt load to do so, in our view serves the best interests of stockholders poorly.
|
·
|
Dhadphale raises only cherry-picked items about the stockholder-nominated director candidates, rather than provide an honest account of each candidate's superb experience and expertise to serve stockholders and transform our company.. Please see our website, www.rxinvestors.com, for a more complete biography of each nominee.
|
·
|
Directors work for the stockholders, not vice versa. A director and an officer bears a fiduciary duty to act in the interest of ALL stockholders, not just those with whom the director and officer may agree, and irrespective of that stockholder's particular voting preferences. Directors should welcome vigorous dialogue from stockholders, and stockholders should always feel free to engage in such dialogue without fear of personal reprisal. Stockholders should NEVER be publicly shamed for participating in a democratic voting process, or for engaging in open and constructive debate about our company's future. And they should NEVER be subject to intimidation by any director or officer who, after all, works for us stockholders, who is paid to represent our best interests, and who should always be mindful of the heightened decorum and responsibility that comes along with the important role of being our stockholders' representative.
|
·
|
review the qualifications of our shareholder-nominated director candidates at www.rxinvestors.com
|
·
|
speak to any candidate with any questions
|
·
|
think carefully about how poorly our company has performed under the current CEO and Board of Directors
|
·
|
engage in open, honest, vigorous debate about our company, without fear of personal reprisal
|
·
|
vote the Blue proxy card to begin the transformation at our company.
|